RecruitingNCT07617974

Natural History of Atrial Fibrillation-Induced Tricuspid Valve Remodeling in the Absence of Significant Tricuspid Regurgitation: A Three-Dimensional Echocardiographic Study

Natural History of Atrial Fibrillation-Induced Tricuspid Valve Remodeling in the Absence of Significant Tricuspid Regurgitation: A Three-Dimensional Echocardiographic Study (TRICUSPID-AF)

Sponsor

Centro Cardiologico Monzino

Enrollment

66 participants

Start Date

May 4, 2026

Study Type

OBSERVATIONAL

Conditions

Atrial Fibrillation (AF)Tricuspid Regurgitation (TR)

Summary

This is a prospective, observational, multicenter study aimed at characterizing tricuspid valve remodeling in patients with atrial fibrillation (AF) without significant tricuspid regurgitation (TR), in relation to AF burden progression.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with atrial fibrillation (af) and tricuspid regurgitation (tr). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Centro Cardiologico Monzino; IRCCS

Milan, Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07617974

Related Trials

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

NCT07626411

Robotic Transjugular Transcatheter Tricuspid Valve Replacement

NCT075161451 location

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

NCT0743095618 locations

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

NCT0717542870 locations

Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation

NCT07405671